Drug
Galcanezumab Gnlm
Galcanezumab Gnlm: highest development phase Approved, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| EMGALITY | Approved |
Latest
No recent events.
Follow Galcanezumab Gnlm on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.